Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Report – Research, Industry Analysis Reports and Market Demands

Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Status, Trends and COVID-19 Impact Report 2021

Request for Sample of this report

Buy now

Table of Content

Section 1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Overview

1.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Scope
1.2 COVID-19 Impact on Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market
1.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Status and Forecast Overview
- 1.3.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Status 2016-2021
- 1.3.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Forecast 2021-2026

Section 2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Manufacturer Share

2.1 Global Manufacturer Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume
2.2 Global Manufacturer Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Revenue

Section 3 Manufacturer Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Introduction

3.1 Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Introduction
- 3.1.1 Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume, Price, Revenue and Gross margin 2016-2021
- 3.1.2 Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Distribution by Region
- 3.1.3 Novartis Interview Record
- 3.1.4 Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Profile
- 3.1.5 Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Specification
3.2 Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Introduction
- 3.2.1 Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume, Price, Revenue and Gross margin 2016-2021
- 3.2.2 Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Distribution by Region
- 3.2.3 Interview Record
- 3.2.4 Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Overview
- 3.2.5 Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Specification
3.3 Manufacturer three Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Introduction
- 3.3.1 Manufacturer three Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume, Price, Revenue and Gross margin 2016-2021
- 3.3.2 Manufacturer three Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Distribution by Region
- 3.3.3 Interview Record
- 3.3.4 Manufacturer three Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Overview
- 3.3.5 Manufacturer three Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Specification

…

Section 4 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (By Region)

Section 5 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (by Product Type)

5.1 Product Introduction by Type
- 5.1.1 Macular Degeneration Drugs Product Introduction
- 5.1.2 Diabetic Retinopathy Drugs Product Introduction
5.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume by Diabetic Retinopathy Drugs016-2021
5.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Diabetic Retinopathy Drugs016-2021
5.4 Different Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Type Price 2016-2021
5.5 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (By Type) Analysis

Section 6 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (by Application)

6.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume by Application 2016-2021
6.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size by Application 2016-2021
6.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price in Different Application Field 2016-2021
6.3 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (By Application) Analysis

Section 7 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (by Channel)

7.1 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (By Channel) Sales Volume and Share 2016-2021
7.2 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (By Channel) Analysis

Section 8 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Forecast 2021-2026

8.1 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Segmentation Market Forecast 2021-2026 (By Region)
8.2 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Segmentation Market Forecast 2021-2026 (By Type)
8.3 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Segmentation Market Forecast 2021-2026 (By Application)
8.4 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Segmentation Market Forecast 2021-2026 (By Channel)
8.5 Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price Forecast

Section 9 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Application and Client Analysis

9.1 50-60 Years Old Customers
9.2 60-70 Years Old Customers

Section 10 Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Manufacturing Cost of Analysis

11.0 Raw Material Cost Analysis

11.0 Labor Cost Analysis

11.0 Cost Overview

Section 11 Conclusion

Section 12 Methodology and Data Source

Chart and Figure

Figure Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Picture

Chart Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (with or without the impact of COVID-19)

Chart Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Growth Rate 2016-2021

Chart Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million $) and Growth Rate 2016-2021

Chart Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Growth Rate 2021-2026

Chart Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million $) and Growth Rate 2021-2026

Chart 2016-2021 Global Manufacturer Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units)

Chart 2016-2021 Global Manufacturer Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume Share

Chart 2016-2021 Global Manufacturer Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Revenue (Million USD)

Chart 2016-2021 Global Manufacturer Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Revenue Share

Chart Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume, Price, Revenue and Gross margin 2016-2021

Chart Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Distribution

Chart Novartis Interview Record (Partly)

Chart Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Profile

Table Novartis Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Specification

Chart Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume, Price, Revenue and Gross margin 2016-2021

Chart Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Distribution

Chart Bayer Healthcare Interview Record (Partly)

Chart Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Business Overview

Table Bayer Healthcare Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Specification

…

Chart United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Market Size (Million $) 2016-2021

Chart United States Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Price (USD/Unit) 2016-2021

Chart Canada Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Market Size (Million $) 2016-2021

Chart Canada Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Price (USD/Unit) 2016-2021

Chart Mexico Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Market Size (Million $) 2016-2021

Chart Mexico Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Price (USD/Unit) 2016-2021

Chart Brazil Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Market Size (Million $) 2016-2021

Chart Brazil Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Price (USD/Unit) 2016-2021

Chart Argentina Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Market Size (Million $) 2016-2021

Chart Argentina Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Price (USD/Unit) 2016-2021

Chart China Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Market Size (Million $) 2016-2021

Chart China Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Price (USD/Unit) 2016-2021

Chart Japan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Market Size (Million $) 2016-2021

Chart Japan Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Price (USD/Unit) 2016-2021

Chart India Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Market Size (Million $) 2016-2021

Chart India Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Price (USD/Unit) 2016-2021

Chart Korea Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Market Size (Million $) 2016-2021

Chart Korea Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Price (USD/Unit) 2016-2021

Chart Southeast Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Market Size (Million $) 2016-2021

Chart Southeast Asia Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Price (USD/Unit) 2016-2021

Chart Germany Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Market Size (Million $) 2016-2021

Chart Germany Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Price (USD/Unit) 2016-2021

Chart UK Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Market Size (Million $) 2016-2021

Chart UK Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Price (USD/Unit) 2016-2021

Chart France Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Market Size (Million $) 2016-2021

Chart France Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Price (USD/Unit) 2016-2021

Chart Spain Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Market Size (Million $) 2016-2021

Chart Spain Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Price (USD/Unit) 2016-2021

Chart Italy Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Market Size (Million $) 2016-2021

Chart Italy Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Price (USD/Unit) 2016-2021

Chart Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Market Size (Million $) 2016-2021

Chart Africa Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Price (USD/Unit) 2016-2021

Chart Middle East Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) and Market Size (Million $) 2016-2021

Chart Middle East Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Price (USD/Unit) 2016-2021

Chart Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation Sales Volume (Units) by Region 2016-2021

Chart Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation Sales Volume (Units) Share by Region 2016-2021

Chart Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation Market size (Million $) by Region 2016-2021

Chart Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation Market size (Million $) Share by Region 2016-2021

Chart Macular Degeneration Drugs Product Figure

Chart Macular Degeneration Drugs Product Description

Chart Diabetic Retinopathy Drugs Product Figure

Chart Diabetic Retinopathy Drugs Product Description

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) by Diabetic Retinopathy Drugs016-2021

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) Share by Type

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million $) by Diabetic Retinopathy Drugs016-2021

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million $) Share by Diabetic Retinopathy Drugs016-2021

Chart Different Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Product Type Price ($/Unit) 2016-2021

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) by Application 2016-2021

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Sales Volume (Units) Share by Application

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million $) by Application 2016-2021

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Size (Million $) Share by Application 2016-2021

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price in Different Application Field 2016-2021

Chart Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (By Channel) Sales Volume (Units) 2016-2021

Chart Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (By Channel) Share 2016-2021

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Segmentation Market Sales Volume (Units) Forecast (by Region) 2021-2026

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Segmentation Market Sales Volume Forecast (By Region) Share 2021-2026

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Segmentation Market Size (Million USD) Forecast (By Region) 2021-2026

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Segmentation Market Size Forecast (By Region) Share 2021-2026

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (By Type) Volume (Units) 2021-2026

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (By Type) Volume (Units) Share 2021-2026

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (By Type) Market Size (Million $) 2021-2026

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (By Application) Market Size (Volume) 2021-2026

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (By Application) Market Size (Volume) Share 2021-2026

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (By Application) Market Size (Value) 2021-2026

Chart Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (By Application) Market Size (Value) Share 2021-2026

Chart Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (By Channel) Sales Volume (Units) 2021-2026

Chart Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Segmentation (By Channel) Share 2021-2026

Chart Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Price Forecast 2021-2026

Chart 50-60 Years Old Customers

Chart 60-70 Years Old Customers

Description

Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Status, Trends and COVID-19 Impact Report 2021
Single User License Report: 2350 USD
Corporate User License Report: 4700 USD
Section Price: As below
Page: 115
Chart and Figure: 142
Publisher: BisReport
Delivery Time: 48 hour

In the past few years, the Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market experienced a huge change under the influence of COVID-19, the global market size of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs reached (2021 Market size XXXX) million $ in 2021 from (2016 Market size XXXX) in 2016 with a CAGR of xxx from 2016-2021 is. As of now, the global COVID-19 Coronavirus Cases have exceeded 200 million, and the global epidemic has been basically under control, therefore, the World Bank has estimated the global economic growth in 2021 and 2022. The World Bank predicts that the global economic output is expected to expand 4 percent in 2021 while 3.8 percent in 2022. According to our research on Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market and global economic environment, we forecast that the global market size of Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs will reach (2026 Market size XXXX) million $ in 2026 with a CAGR of % from 2021-2026.

Due to the COVID-19 pandemic, according to World Bank statistics, global GDP has shrunk by about 3.5% in 2020. Entering 2021, Economic activity in many countries has started to recover and partially adapted to pandemic restrictions. The research and development of vaccines has made breakthrough progress, and many governments have also issued various policies to stimulate economic recovery, particularly in the United States, is likely to provide a strong boost to economic activity but prospects for sustainable growth vary widely between countries and sectors. Although the global economy is recovering from the great depression caused by COVID-19, it will remain below pre-pandemic trends for a prolonged period. The pandemic has exacerbated the risks associated with the decade-long wave of global debt accumulation. It is also likely to steepen the long-expected slowdown in potential growth over the next decade.

The world has entered the COVID-19 epidemic recovery period. In this complex economic environment, we published the Global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs Market Status, Trends and COVID-19 Impact Report 2021, which provides a comprehensive analysis of the global Age Related Macular Degeneration (AMD) and Diabetic Retinopathy (DR) Drugs market , This Report covers the manufacturer data, including: sales volume, price, revenue, gross margin, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows the regional development status, including market size, volume and value, as well as price data. Besides, the report also covers segment data, including: type wise, industry wise, channel wise etc. all the data period is from 2015-2021E, this report also provide forecast data from 2021-2026.

Section 1: 100 USD——Market Overview

Section (2 3): 1200 USD——Manufacturer Detail
Novartis
Bayer Healthcare
Roche
Neurotech Pharmaceuticals
Regeneron Pharmaceuticals
Allergan

Section 4: 900 USD——Region Segmentation
North America (United States, Canada, Mexico)
South America (Brazil, Argentina, Other)
Asia Pacific (China, Japan, India, Korea, Southeast Asia)
Europe (Germany, UK, France, Spain, Italy)
Middle East and Africa (Middle East, Africa)

Section (5 6 7): 700 USD——
Product Type Segmentation
Macular Degeneration Drugs
Diabetic Retinopathy Drugs

Application Segmentation
50-60 Years Old
60-70 Years Old

Channel (Direct Sales, Distribution Channel) Segmentation

Section 8: 500 USD——Market Forecast (2021-2026)

Section 9: 600 USD——Downstream Customers

Section 10: 200 USD——Raw Material and Manufacturing Cost

Section 11: 500 USD——Conclusion

Section 12: Research Method and Data Source